- Home
- EHLD vs ZLAB Comparison
EHLD vs ZLAB Comparison
Compare EHLD & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHLD
- ZLAB
- Stock Information
- Founded
- EHLD 2024
- ZLAB 2013
- Country
- EHLD Greece
- ZLAB China
- Employees
- EHLD N/A
- ZLAB N/A
- Industry
- EHLD
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- EHLD
- ZLAB Health Care
- Exchange
- EHLD NYSE
- ZLAB Nasdaq
- Market Cap
- EHLD 17.2M
- ZLAB 3.6B
- IPO Year
- EHLD N/A
- ZLAB 2017
- Fundamental
- Price
- EHLD $8.33
- ZLAB $32.54
- Analyst Decision
- EHLD
- ZLAB Buy
- Analyst Count
- EHLD 0
- ZLAB 5
- Target Price
- EHLD N/A
- ZLAB $54.28
- AVG Volume (30 Days)
- EHLD 56.6K
- ZLAB 781.8K
- Earning Date
- EHLD 08-15-2025
- ZLAB 08-05-2025
- Dividend Yield
- EHLD 6.67%
- ZLAB N/A
- EPS Growth
- EHLD N/A
- ZLAB N/A
- EPS
- EHLD 4.74
- ZLAB N/A
- Revenue
- EHLD $14,687,504.00
- ZLAB $418,326,000.00
- Revenue This Year
- EHLD N/A
- ZLAB $44.07
- Revenue Next Year
- EHLD N/A
- ZLAB $49.13
- P/E Ratio
- EHLD $1.78
- ZLAB N/A
- Revenue Growth
- EHLD N/A
- ZLAB 43.72
- 52 Week Low
- EHLD $3.83
- ZLAB $16.01
- 52 Week High
- EHLD $12.80
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- EHLD N/A
- ZLAB 40.19
- Support Level
- EHLD N/A
- ZLAB $34.26
- Resistance Level
- EHLD N/A
- ZLAB $35.72
- Average True Range (ATR)
- EHLD 0.00
- ZLAB 1.12
- MACD
- EHLD 0.00
- ZLAB -0.54
- Stochastic Oscillator
- EHLD 0.00
- ZLAB 3.83
About EHLD EUROHOLDINGS LTD
Euroholdings Ltd is a provider of shipping transportation services. The company specializes in the ownership of vessels. The fleet of the company consists of containerships that transport container boxes providing scheduled service between ports.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.